vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and NATIONAL FUEL GAS CO (NFG). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $425.9M, roughly 1.2× NATIONAL FUEL GAS CO). NATIONAL FUEL GAS CO runs the higher net margin — 35.7% vs 6.8%, a 28.9% gap on every dollar of revenue. On growth, NATIONAL FUEL GAS CO posted the faster year-over-year revenue change (1.7% vs -1.7%). Over the past eight quarters, NATIONAL FUEL GAS CO's revenue compounded faster (12.1% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
National Fuel Gas Company is a diversified energy company with $6.2 billion in assets distributed among the following five operating segments: Exploration and Production, Pipeline and Storage, Gathering, Utility, and Energy Marketing. National Fuel Gas was incorporated in 1902 and is based in Williamsville, New York.
MD vs NFG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $425.9M |
| Net Profit | $33.7M | $152.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 81.5% |
| Net Margin | 6.8% | 35.7% |
| Revenue YoY | -1.7% | 1.7% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.9M | ||
| Q4 25 | $493.8M | $637.9M | ||
| Q3 25 | $492.9M | $443.1M | ||
| Q2 25 | $468.8M | $527.4M | ||
| Q1 25 | $458.4M | $734.8M | ||
| Q4 24 | $502.4M | $513.8M | ||
| Q3 24 | $511.2M | $310.0M | ||
| Q2 24 | $504.3M | $338.6M |
| Q1 26 | — | $152.0M | ||
| Q4 25 | $33.7M | $181.6M | ||
| Q3 25 | $71.7M | $107.3M | ||
| Q2 25 | $39.3M | $149.8M | ||
| Q1 25 | $20.7M | $216.4M | ||
| Q4 24 | $30.5M | $45.0M | ||
| Q3 24 | $19.4M | $-167.6M | ||
| Q2 24 | $-153.0M | $-54.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 94.7% | ||
| Q1 25 | — | 81.6% | ||
| Q4 24 | — | 87.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.5% |
| Q1 26 | — | 81.5% | ||
| Q4 25 | 9.9% | 43.3% | ||
| Q3 25 | 13.8% | 40.6% | ||
| Q2 25 | 12.8% | 43.7% | ||
| Q1 25 | 7.0% | 43.2% | ||
| Q4 24 | 7.8% | 16.8% | ||
| Q3 24 | 6.6% | -63.4% | ||
| Q2 24 | -31.3% | -15.2% |
| Q1 26 | — | 35.7% | ||
| Q4 25 | 6.8% | 28.5% | ||
| Q3 25 | 14.5% | 24.2% | ||
| Q2 25 | 8.4% | 28.4% | ||
| Q1 25 | 4.5% | 29.4% | ||
| Q4 24 | 6.1% | 8.8% | ||
| Q3 24 | 3.8% | -54.1% | ||
| Q2 24 | -30.3% | -16.0% |
| Q1 26 | — | $1.59 | ||
| Q4 25 | $0.40 | $1.98 | ||
| Q3 25 | $0.84 | $1.18 | ||
| Q2 25 | $0.46 | $1.64 | ||
| Q1 25 | $0.24 | $2.37 | ||
| Q4 24 | $0.37 | $0.49 | ||
| Q3 24 | $0.23 | $-1.81 | ||
| Q2 24 | $-1.84 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | $300.0M |
| Stockholders' EquityBook value | $865.9M | — |
| Total Assets | $2.2B | $9.1B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | $271.4M | ||
| Q3 25 | $340.1M | $43.2M | ||
| Q2 25 | $224.7M | $39.3M | ||
| Q1 25 | $99.0M | $40.0M | ||
| Q4 24 | $229.9M | $48.7M | ||
| Q3 24 | $103.8M | $38.2M | ||
| Q2 24 | $19.4M | $81.4M |
| Q1 26 | — | $300.0M | ||
| Q4 25 | $570.5M | $2.7B | ||
| Q3 25 | $577.2M | $2.7B | ||
| Q2 25 | $583.9M | $2.7B | ||
| Q1 25 | $590.5M | $2.7B | ||
| Q4 24 | $597.1M | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | $865.9M | $3.6B | ||
| Q3 25 | $890.7M | $3.1B | ||
| Q2 25 | $833.8M | $3.0B | ||
| Q1 25 | $789.2M | $2.8B | ||
| Q4 24 | $764.9M | $-76.2M | ||
| Q3 24 | $732.5M | $-15.5M | ||
| Q2 24 | $706.5M | $5.0M |
| Q1 26 | — | $9.1B | ||
| Q4 25 | $2.2B | $9.2B | ||
| Q3 25 | $2.2B | $8.7B | ||
| Q2 25 | $2.1B | $8.4B | ||
| Q1 25 | $2.0B | $8.5B | ||
| Q4 24 | $2.2B | $8.3B | ||
| Q3 24 | $2.1B | $8.3B | ||
| Q2 24 | $2.0B | $8.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 0.75× | ||
| Q3 25 | 0.65× | 0.87× | ||
| Q2 25 | 0.70× | 0.90× | ||
| Q1 25 | 0.75× | 0.99× | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 532.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $657.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 117.0% |
| Cash ConversionOCF / Net Profit | 3.39× | 4.32× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $657.3M | ||
| Q4 25 | $114.1M | $274.9M | ||
| Q3 25 | $137.3M | $237.8M | ||
| Q2 25 | $137.2M | $388.4M | ||
| Q1 25 | $-117.5M | $253.8M | ||
| Q4 24 | $133.0M | $220.1M | ||
| Q3 24 | $91.8M | $197.9M | ||
| Q2 24 | $107.0M | $281.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.7M | ||
| Q3 25 | — | $-47.8M | ||
| Q2 25 | — | $195.3M | ||
| Q1 25 | — | $59.9M | ||
| Q4 24 | — | $-20.3M | ||
| Q3 24 | — | $-49.1M | ||
| Q2 24 | — | $79.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.4% | ||
| Q3 25 | — | -10.8% | ||
| Q2 25 | — | 37.0% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | -4.0% | ||
| Q3 24 | — | -15.8% | ||
| Q2 24 | — | 23.5% |
| Q1 26 | — | 117.0% | ||
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 64.4% | ||
| Q2 25 | — | 36.6% | ||
| Q1 25 | — | 26.4% | ||
| Q4 24 | — | 46.8% | ||
| Q3 24 | — | 79.7% | ||
| Q2 24 | — | 59.7% |
| Q1 26 | — | 4.32× | ||
| Q4 25 | 3.39× | 1.51× | ||
| Q3 25 | 1.91× | 2.21× | ||
| Q2 25 | 3.49× | 2.59× | ||
| Q1 25 | -5.66× | 1.17× | ||
| Q4 24 | 4.36× | 4.89× | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
NFG
| Revenues from External Customers | $425.8M | 100% |
| Intersegment Revenues | $126.0K | 0% |
